BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15618220)

  • 1. Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
    Hu X; Haney N; Kropp D; Kabore AF; Johnston JB; Gibson SB
    J Biol Chem; 2005 Mar; 280(10):9498-508. PubMed ID: 15618220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
    Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
    Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
    Hu X; Mendoza FJ; Sun J; Banerji V; Johnston JB; Gibson SB
    Cell Signal; 2008 Jun; 20(6):1198-208. PubMed ID: 18396013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
    Jones DT; Ganeshaguru K; Anderson RJ; Jackson TR; Bruckdorfer KR; Low SY; Palmqvist L; Prentice HG; Hoffbrand AV; Mehta AB; Wickremasinghe RG
    Blood; 2003 Apr; 101(8):3174-80. PubMed ID: 12480711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.
    Sautin YY; Crawford JM; Svetlov SI
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C2010-9. PubMed ID: 11698260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
    Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
    Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
    Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
    Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
    Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
    Martinez-Lostao L; Briones J; Martinez-Gallo M; Forné I; Sierra J; Rodriguez-Sanchez JL; Juarez C
    Leuk Lymphoma; 2004 Nov; 45(11):2307-14. PubMed ID: 15512822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
    Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB
    Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
    König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
    Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis.
    Deng W; Balazs L; Wang DA; Van Middlesworth L; Tigyi G; Johnson LR
    Gastroenterology; 2002 Jul; 123(1):206-16. PubMed ID: 12105849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
    Battle TE; Arbiser J; Frank DA
    Blood; 2005 Jul; 106(2):690-7. PubMed ID: 15802533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
    Wang P; Pavletic ZS; Joshi SS
    Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.
    Kojima K; Konopleva M; McQueen T; O'Brien S; Plunkett W; Andreeff M
    Blood; 2006 Aug; 108(3):993-1000. PubMed ID: 16543464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
    Johnston JB; Kabore AF; Strutinsky J; Hu X; Paul JT; Kropp DM; Kuschak B; Begleiter A; Gibson SB
    Oncogene; 2003 Nov; 22(51):8356-69. PubMed ID: 14614459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism.
    Mengubas K; Riordan FA; Bravery CA; Lewin J; Owens DL; Mehta AB; Hoffbrand AV; Wickremasinghe RG
    Oncogene; 1999 Apr; 18(15):2499-506. PubMed ID: 10229201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.